Farmacia online e piattaforma healthcare (API Holdings).
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Debt API Holdings (PharmEasy) raised INR 1.700 Cr (~$193M) via NCDs, pledging 61% of Thyrocare, to refinance existing debt. | $193M |
| Apr 2024 | Funding round Epharmacy PharmEasy raised INR 1,804 Cr (~$216.2M) in a rights-issue down round (90% valuation cut) led by MEMG Family Office, with Prosus, Temasek and 360 One. | $216.2M |
| Oct 2022 | Bridge Epharmacy PharmEasy launched a rights issue to raise up to INR 750 Cr (~$91M) via convertible notes from existing investors including Prosus Ventures and Temasek after shelving its IPO. | $91M |
| Jun 2021 | Funding round PharmEasy's valuation rose to ~$1.8B after B Capital bought a minority stake via a $20M secondary transaction. | $20M |
| Apr 2021 | Series D Plus Epharmacy PharmEasy (API Holdings) became a unicorn with a $323M Series E from Prosus Ventures and TPG Growth at a $1.5B valuation. | $323M |